文献速递乳房整形与再造创面修复

局部去铁胺减轻小鼠乳房再造模型放疗后皮肤损伤并正常化原子力显微镜模式

Topical Deferoxamine Alleviates Skin Injury and Normalizes Atomic Force Microscopy Patterns Following Radiation in a Murine Breast Reconstruction Model.
PubMed 文献 · Ann Plast Surg · 2018-01-01

该研究在小鼠扩张器乳房再造模型中,评估局部去铁胺(DFO)对放疗后皮肤溃疡和胶原紊乱的作用。15只雌性大鼠分对照、放疗和DFO三组,放疗为分次28 Gy,DFO局部应用10天。结果显示DFO显著减少溃疡和I型胶原纤维紊乱,与对照组无统计学差异。

要点

  • 局部DFO可显著减少放疗后皮肤溃疡发生率。
  • 局部DFO可显著改善I型胶原纤维排列紊乱。
  • DFO组与对照组在溃疡和胶原紊乱上无统计学差异。

核心结论

  • 局部去铁胺可减少放疗后皮肤溃疡和I型胶原纤维紊乱,有望改善扩张器乳房再造结局。

研究设计与样本

  • 雌性Sprague-Dawley大鼠15只,分对照(扩张器)、XRT(扩张器+放疗)、DFO(扩张器+放疗+去铁胺)三组。
  • 扩张器置于右上背皮下肌肉平面,最终填充至15 mL;放疗为分次28 Gy;放疗后局部去铁胺应用10天,恢复20天后分析。

主要发现

  • 与对照组相比,XRT组皮肤溃疡显著增加(3.7% vs 43.3%,P=0.00),胶原纤维紊乱显著增加(26.3% vs 81.8%,P=0.00)。
  • 与XRT组相比,局部DFO显著减少溃疡(43.3% vs 7.0%,P=0.00)和纤维紊乱(81.8% vs 15.3%,P=0.00)。
  • 对照组与DFO组在皮肤溃疡或胶原紊乱上无统计学差异。

临床怎么用

  • 局部去铁胺可能作为放疗后乳房再造患者减少皮肤损伤的辅助治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Breast cancer is most commonly managed with a combination of tumor ablation, radiation, and/or chemotherapy. Despite the oncologic benefit of these treatments, the detrimental effect of radiation on surrounding tissue challenges the attainment of ideal breast reconstruction outcomes. The purpose of this study was to determine the ability of topical deferoxamine (DFO) to reduce cutaneous ulceration and collagen disorganization following radiotherapy in a murine model of expander-based breast reconstruction. METHODS: Female Sprague-Dawley rats (n = 15) were divided into 3 groups: control (expander), XRT (expander + radiation), and DFO (expander + radiation + deferoxamine [DFO]). Expanders were placed in a submusculocutaneous plane in the right upper back and ultimately filled to 15 mL. Radiation was administered via a fractionated dose of 28 Gy. Deferoxamine was delivered topically for 10 days following radiation. After a 20-day recovery period, skin ulceration and dermal type I collagen organization were analyzed. RESULTS: Compared with control, the XRT group demonstrated a significant increase in skin ulceration (3.7% vs 43.3%, P = 0.00) and collagen fibril disorganization (26.3% vs 81.8%, P = 0.00). Compared with the XRT group, treatment with topical DFO resulted in a significant reduction in ulceration (43.3% vs 7.0%, P = 0.00) and fibril disorganization (81.8% vs 15.3%, P = 0.00). There were no statistical differences between the control and DFO groups in skin ulceration or collagen disorganization. CONCLUSIONS: This study suggests topical DFO is capable of reducing skin ulceration and type I collagen fibril disorganization following radiotherapy. This novel application of DFO has potential to enhance expander-based breast reconstruction outcomes and improve quality of life for women suffering the devastating effects of breast cancer.

来源:Ann Plast Surg,查看原文。版权归原作者所有。

引用

  1. Snider AE, Lynn JV, Urlaub KM, et al. Topical Deferoxamine Alleviates Skin Injury and Normalizes Atomic Force Microscopy Patterns Following Radiation in a Murine Breast Reconstruction Model. Ann Plast Surg. 2018. PMID: 30113984. doi:10.1097/SAP.0000000000001592

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。